Pharmacokinetic/ Pharmacodynamics in Drug Development and Evaluation
Who takes these points in consideration ?
1. Industry: surely ! (for sake of efficacy) but what do they do with that ?
2. Clinicians: more and more (to optimize therapy) but they often feel alone or unsufficiently informed
3. Regulatory bodies (to better appraise new drugs) bet they wish to be certain that this is the correct way !